Fuji Keizai Releases Report on Japanese Immunoassay Market.Tokyo, Japan, Jan 19, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Japanese market researcher Fuji Keizai has published a report on the immunoassay Immunoassay An assay that quantifies antigen or antibody by immunochemical means. The antigen can be a relatively simple substance such as a drug, or a complex one such as a protein or a virus. market in Japan. The report estimates that the market for diagnostic products reached about 327.5 billion yen ($2.85 bil) in 2005, of which the immunoassay sector accounted for a little under 50%, reaching 154 billion yen ($1.33 bil). In particular, the influenza antigen rapid test kit sector demonstrated significant growth. In line with the flu epidemic in 2004, it is expected to have reached 15.5 billion yen ($134.7 mil) in 2005, up from 10 billion yen ($87.0 mil) in 2003. In addition, three segments in the immunoassay market showed sound growth. They are chemiluminescent chem·i·lu·mi·nes·cence n. Emission of light as a result of a chemical reaction at environmental temperatures. chem assay, latex assay and immunochromato/gold colloid colloid (kŏl`oid) [Gr.,=gluelike], a mixture in which one substance is divided into minute particles (called colloidal particles) and dispersed throughout a second substance. assay. Entitled Immunoassay Market 2006, the 292-page report (available only in Japanese) sells for 200,000 yen ($1,740). Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion